UCB, Daiichi Sankyo to offer new treatment option for epilepsy

Japan |  News | 0 Comment | 02 Mar, 2020

UCB Japan Co., Ltd, and Daiichi Sankyo Company, Limited are pleased to announce that a supplemental application for VIMPAT® (generic name: lacosamide) was filed in Japan to expand the i...Read more

Takeda acquires PvP Biologics focusing on celiac disease treatment

Japan |  News | 0 Comment | 28 Feb, 2020

Japan based Takeda Pharmaceutical Company Limited announced that it has acquired US based PvP Biologics, Inc. following the conclusion of a Phase 1 proof-of-mechanism study of investig...Read more

Eisai, FUJI YAKUHIN to work on hyperuricemia and gout treatment

Japan |  News | 1 Comment | 27 Feb, 2020

Japan based Eisai Co., Ltd. and FUJI YAKUHIN CO., LTD.  have concluded a license agreement concerning dotinurad (generic name), a treatment for hyperuricemia and gout discovered by FUJ...Read more

Softbank leads $165 M funding for Karius

Japan |  News | 0 Comment | 26 Feb, 2020

Japanese multinational conglomerate holding company SoftBank Group led the new funding round for US based firm Karius, the world leader in liquid biopsy for infectious diseases. K...Read more

Eisai receives recognition for contribution towards liver diseases

Japan |  News | 0 Comment | 25 Feb, 2020

Japan based pharmaceutical firm Eisai announced that it has received the President’s Award at the 8th Technology Management and Innovation Awards held by the Japan Techno-Economics So...Read more

Eisai’s H3 Biomedicine appoints new CMO

Japan |  News | 0 Comment | 24 Feb, 2020

H3 Biomedicine, Inc. (H3), precision medicine research & development subsidiary of Eisai Co has announced the appointment of Antonio Gualberto, MD, PhD, to the position of Chief Me...Read more

BIO cancels Asia conference in Tokyo amid COVID-19 outbreak

Japan |  News | 0 Comment | 24 Feb, 2020

The Biotechnology Innovation Organization (BIO) has announced, it is canceling the annual BIO Asia conference in Tokyo scheduled for March 10-11. The decision was based on the global impact...Read more

BitOne enhances remote medical services with 5G technology

Japan |  News | 0 Comment | 19 Feb, 2020

Japan based BitOne Group Company Limited and IBO Telecom Company Limited, a Hong Kong-based subsidiary of IBO Technology Company Limited are pleased to announce that they have signed a...Read more

Chugai receives Orphan Drug Designation for RG6042

Japan |  News | 0 Comment | 18 Feb, 2020

Japan based Chugai Pharmaceutical has announced that the Ministry of Health, Labour and Welfare (MHLW) has designated the company’s investigational medicine RG6042 as an orp...Read more

Researchers investigate cancer genomic landscape of Japan

Japan |  News | 0 Comment | 17 Feb, 2020

Tokyo Medical and Dental University (TMDU), ACT Genomics (Taipei, Taiwan), and ACTmed (Japan) launched a joint clinical research collaboration aimed to establish comprehensive genomic profi...Read more

Japan explores muscular dystrophy associated cardiomyopathy

Japan |  News | 0 Comment | 14 Feb, 2020

In a study recently published in Nature Communications, scientists at Japan based Okayama University describe the detailed molecular pathogenesis of muscular dystrophy-associated ...Read more

Foundation Medicine & Chugai announce partnership with NCC

Japan |  News | 0 Comment | 13 Feb, 2020

Foundation Medicine, Inc. and Chugai Pharmaceutical Co., Ltd. have entered into an agreement with the National Cancer Center (NCC) for the use of FoundationOne®...Read more

Nippon Shinyaku inks new agreement for prostate cancer treatment

Japan |  News | 0 Comment | 12 Feb, 2020

Japan based Nippon Shinyaku Co., LTD. has announced that Janssen Pharmaceutical K.K. and Nippon Shinyaku entered into a new co-promotion agreement about ZYTIGA® (abiraterone acetate) fo...Read more

Japan suggests combined drug treatment for lung cancer

Japan |  News | 0 Comment | 11 Feb, 2020

Researchers at Japan based Kanazawa University report in the Journal of Thoracic Oncology a promising novel approach for a combined treatment of the most common type of lung cance...Read more

Chugai collaborates with National Cancer Center

Japan |  News | 0 Comment | 10 Feb, 2020

Japanese firm Chugai Pharmaceutical Co., Ltd. has announced that it has entered into an agreement with National Cancer Center, Japan to support an investigator-initiated clinical study base...Read more

Santen, Verily to develop unique ophthalmic devices

Japan |  News | 0 Comment | 07 Feb, 2020

Japan based Santen Pharmaceutical Co., Ltd. and US based Verily, an Alphabet company, have announced the establishment of a joint venture focused on applying microelectronics and scalable d...Read more

Sumitomo Dainippon, Exscientia begin clinical study of AI based OCD drug

Japan |  News | 0 Comment | 03 Feb, 2020

Japan based Sumitomo Dainippon Pharma Co., Ltd. and UK based Exscientia Ltd. have announced that a phase I clinical study of DSP-1181, that was created using Artificial Intelligence (AI), h...Read more

Japan unveils herbal medicines to treat stomach disorders

Japan |  News | 0 Comment | 30 Jan, 2020

In a recent study researchers at Okayama University, Japan illustrate the potential of berberine, a herbal Chinese medicine, in reducing inflammation within the digestive tract. Inflammato...Read more